Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
Go back to Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration| (NASDAQ: GCTK) | Delayed: 1.26 -0.15 (10.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.41 | 52 Week High | $ | |||
| Open | $1.34 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 134,803 | |||||
